SOHO 2019 - Annual Meeting of the Society of Hematologic Oncology
Sep 11 - Sep 14, 2019 | HoustonTXUS
LARVOL is not affiliated with Annual Meeting of the Society of Hematologic Oncology and all trademarks, logos, and brand names are property of their respective owners
Showing 143 abstracts linked to Trials
MODULE 1: Evolving Therapeutic Algorithms for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia (CLL)
MODULE 2: Existing and Recently Approved Approaches for Patients with Relapsed/Refractory (R/R) CLL — Dr Flowers
MODULE 4: Available Data with and Potential Role of Novel Combination Approaches
Childhood Acute Lymphoblastic Leukemia: How to Cure the Very High Risk?
IDH Inhibitors in AML
Identification for and Management of Patients with PV and MF with Ruxolitinib
Myelofibrosis Management After Ruxolitinib Failure
Life Beyond RVD: The Future of Induction Therapy for Multiple Myeloma
CML Case Studies: Impact of Comorbidities
Primer on CNL and aCML Diagnosis and Therapy
Identifying and Treating “Progression” in Myelofibrosis
Role of Autologous Stem Cell Transplantation in Myeloma: 2019
Multiple Myeloma: Minimal Residual Disease Testing – Not Ready for Primetime
Amyloid Therapy and Targets
Targeting Apoptosis Pathways in Acute Myeloid Leukemia